Search Results 671-680 of 17906 for Assay
Kidney Cancer · Bladder Cancer · Minimal Residual Disease Assays · Clinical Trials ...
... assayed from blood of cases with CAP and controls without history of cancer. A Study to Improve the Use of Genetic Testing in Disease Prevention and ...
Shapiro utilized hemodynamic catheterization to characterize ventricular pressure and volume loops, immunohistochemistry and various assays to demonstrate ...
- Serum free light chains (FLC) assay: Involved FLC assay ≥10 mg/dL (≥100 mg/L) and an abnormal serum FLC ratio (<0.26 or >1.65) - Measurable bone or ...
The detection of SRP-IgG is facilitated by a highly sensitive immunofluorescence-based assay that can discern the distinctive, characteristic pattern in a ...
... assay of glycolytic enzymes and CPT2 ( “myoglobinuria panel”). Subjects with muscular dystrophy and non-specific dystrophic changes on muscle biopsy, normal ...
... assay, reduced microglial activation, and improved cognitive deficits. These data imply a central role for extracellular tau aggregates in the development ...
Liver function tests are blood tests used to help find the cause of your symptoms and monitor liver disease or damage. The tests measure the levels of certain ...
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease (CAMPERR). Rochester, Minn. The purpose of this ...
Classification of BRCA2 variants of uncertain significance (VUS) using an ACMG/AMP model incorporating a homology-directed repair (HDR) functional assay.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!